Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,115,869 | 1,599,113 | 1,697,275 | 1,481,836 | 1,502,648 |
| Marketable Securities | N/A | 0 | 30,000 | 255,997 | 435,923 |
| Receivables | 152,990 | 149,787 | 127,520 | 118,203 | 101,340 |
| Inventories | 186,212 | 288,469 | 268,756 | 240,333 | 231,961 |
| Other current assets | 149,028 | 147,941 | 141,666 | 174,981 | 213,324 |
| TOTAL | $2,604,099 | $2,185,310 | $2,265,217 | $2,271,350 | $2,485,196 |
| Non-Current Assets | |||||
| PPE Net | 191,156 | 199,249 | 203,330 | 203,107 | 190,430 |
| Intangibles | 14,239 | 14,204 | 14,105 | 14,124 | 13,628 |
| Other Non-Current Assets | 338,480 | 263,455 | 276,421 | 276,652 | 295,464 |
| TOTAL | $543,875 | $476,908 | $493,856 | $493,883 | $499,522 |
| Total Assets | $3,147,974 | $2,662,218 | $2,759,073 | $2,765,233 | $2,984,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 76,741 | 44,163 | 76,681 | 76,651 | 111,090 |
| Accrued Expenses | 271,697 | 221,009 | 240,141 | 180,636 | 193,553 |
| Other current liabilities | 15,051 | 19,027 | 18,956 | 18,205 | 22,139 |
| TOTAL | $452,733 | $373,443 | $425,022 | $364,736 | $416,026 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,096,876 | 1,094,912 | 1,092,985 | 1,091,110 | 992,493 |
| Deferred Revenues | 89,244 | 89,244 | 89,244 | 89,244 | 89,244 |
| Other Non-Current Liabilities | 96,112 | 127,597 | 136,725 | 132,459 | 150,952 |
| TOTAL | $1,767,232 | $1,819,247 | $1,848,943 | $1,865,052 | $1,806,933 |
| Total Liabilities | $2,219,965 | $2,192,690 | $2,273,965 | $2,229,788 | $2,222,959 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,150 | 87,077 | 79,845 | 79,775 | 79,421 |
| Common Shares | 9 | 8 | 8 | 8 | 8 |
| Retained earnings | -3,206,748 | -3,084,767 | -3,036,623 | -2,955,218 | -2,848,129 |
| Other shareholders' equity | -20 | -20 | 2 | -3 | 3 |
| TOTAL | $928,009 | $469,528 | $485,108 | $535,445 | $761,759 |
| Total Liabilities And Equity | $3,147,974 | $2,662,218 | $2,759,073 | $2,765,233 | $2,984,718 |